clarithromycin has been researched along with Tuberculosis in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 29 (51.79) | 18.2507 |
2000's | 15 (26.79) | 29.6817 |
2010's | 6 (10.71) | 24.3611 |
2020's | 6 (10.71) | 2.80 |
Authors | Studies |
---|---|
Agrawal, A; Garg, G; Kumar, R; Li, J; Pande, M | 1 |
Akrami, S; Dokht Khosravi, A; Hashemzadeh, M | 1 |
Daneshfar, S; Hashemzadeh, M; Khosravi, AD | 1 |
Garg, S; Kumar, R; Kunimoto, D; Rayat, GR | 1 |
Cai, Y; Deng, Z; Fan, S; Fu, X; Li, J; Li, SS; Ma, J; Ma, W; Sun, QH; Sun, YC; Xue, S | 1 |
Lindeboom, JA | 1 |
Abolghasemi, S; Mobasher Aghdam, A; Sali, S; Shahrbaf, MA | 1 |
Addo, KK; Addo, SO; Bonsu, FA; Mensah, GI; Mosi, L | 1 |
Böttger, EC; Bruhn, DF; Lee, RE; Lenaerts, AJ; Liu, J; Meibohm, B; Scherbakov, D; Scherman, MS | 1 |
Kim, BJ; Kim, HY; Kook, Y; Kook, YH; Lee, NY; Park, CG; Shim, TS; Yun, YJ | 1 |
Khan, DA; Laurie, SA; Ruiz-Huidobro, E; Swamy, N | 1 |
Ichikawa, K; Inagaki, T; Moriyama, M; Nakagawa, T; Nikai, T; Ogawa, K; Uchiya, K; Yagi, T | 1 |
Ankomah, P; Levin, BR | 1 |
Rondón-Lugo, A; Torres-Rojas, JR; Vidal, R | 1 |
Aish, L; Gaur, S; Trayner, E; Weinstein, R | 1 |
Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
Corti, ME; Palmero, DJ | 1 |
Greene, CE; Latimer, KS; Sanchez, S; Sessions, JK; Sieber-Ruckstuhl, NS | 1 |
Bakker-Woudenberg, IA; de Steenwinkel, JE; Schiffelers, RM; Ten Kate, MT; van Agtmael, MA; van Vianen, W; Verbrugh, HA | 1 |
Shirasaka, T | 1 |
Barradell, LB; McTavish, D; Plosker, GL | 1 |
Bermudez, LE; Inderlied, CB; Kolonoski, P; Petrofsky, M; Young, LS | 1 |
Bertrand, G; Cohen, Y; Grosset, J; Lounis, N; Perronne, C; Pocidalo, JJ; Struillou, L; Vildé, JL | 1 |
Farrer, J; Furney, SK; Orme, IM; Skinner, PS | 1 |
Cynamon, MH; Klemens, SP | 2 |
Bermudez, LE; Inderlied, CB; Kolonoski, P; Young, LS | 1 |
Grosset, J; Lazard, T; Perronne, C; Pocidalo, JJ; Vilde, JL | 1 |
Heifets, L; Mor, N | 1 |
Saito, H; Sato, K; Tomioka, H | 1 |
Daneluzzi, D; Gangadharam, PR; Luna-Herrera, J; Reddy, VM | 1 |
Grosset, JH; Ji, B; Lounis, N; Truffot-Pernot, C | 1 |
Goh, KS; Labrousse, V; Rastogi, N | 1 |
Amitani, R; Kuze, F; Murayama, T; Suzuki, K; Tanaka, E; Yamamoto, T | 1 |
Grosset, J; Ji, B; Lounis, N; Truffot-Pernot, C | 2 |
Akaki, T; Kawahara, S; Sato, K; Shimizu, T; Tomioka, H | 1 |
Esfandiari, A; Mor, N | 1 |
Brel, F; Lecompte, T; May, T; Picardeau, M; Varnerot, A; Vincent, V | 1 |
Clumeck, N; De Wit, S; Payen, MC | 1 |
Akaki, T; Sato, K; Tomioka, H | 1 |
Creti, R; Fattorini, L; Iona, E; Li, Y; Mattei, M; Orefici, G; Ricci, ML; Thoresen, OF; Xiao, Y | 1 |
Doherty, TM; Sher, A | 1 |
Bermudez, LE; Petrofsky, M; Wu, M; Young, LS | 1 |
Bombana, E; Chatel, G; Matteelli, A; Pinsi, G; Signorini, L; Tebaldi, A | 1 |
Fattorini, L; Iona, E; Li, Y; Mattei, M; Orefici, G; Thoresen, OF; Xiao, Y | 1 |
Fonquernie, L; Frottier, J; Kirstetter, M; Le Van, JC; Meynard, JL; Meyohas, MC; Prévot, S | 1 |
Barros, V; Bosne-David, S; David, HL; Portugal, C; Verde, SC | 1 |
Akaki, T; Kawahara, S; Sato, K; Tomioka, H | 1 |
Bowersox, J | 1 |
Appelberg, R; Gonçalves, AS | 1 |
Baird, SM; Carson, DA; Catanzaro, A; Hayashi, T; Kornbluth, RS; Rao, SP; Raz, E; Takabayashi, K; Taylor, MW; Van Uden, JH | 1 |
Carbonara, S; Costa, D; D'Aprile, A; Maggi, P; Monno, R; Pastore, G; Sibilio, G | 1 |
Cynamon, MH; DeStefano, MS; Klemens, SP | 1 |
Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
5 review(s) available for clarithromycin and Tuberculosis
Article | Year |
---|---|
[Anti-retroviral treatment in patients with AIDS and mycobacterial diseases].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Retroviral Agents; Clarithromycin; Drug Interactions; Humans; Mycobacterium Infections; Rifampin; Tuberculosis | 2005 |
[Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; CD4-Positive T-Lymphocytes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Lymphocyte Count; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Rifabutin; Tuberculosis | 2007 |
Clarithromycin.
Topics: Animals; Antitubercular Agents; Clarithromycin; Humans; Mice; Rats; Treatment Outcome; Tuberculosis | 2008 |
Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Animals; Clarithromycin; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Tuberculosis | 1993 |
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
Topics: Activities of Daily Living; AIDS-Related Opportunistic Infections; Amikacin; Anemia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cause of Death; Chemoprevention; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Fever; Granulocyte Colony-Stimulating Factor; Health Status; Humans; Immunocompromised Host; Immunotherapy; Incidence; Interferon-gamma; Molecular Biology; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin; Tuberculosis; Virulence; Weight Loss | 1997 |
51 other study(ies) available for clarithromycin and Tuberculosis
Article | Year |
---|---|
Investigation of 4-amino-5-alkynylpyrimidine-2(1H)-ones as anti-mycobacterial agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrimidinones; Structure-Activity Relationship; Tuberculosis | 2016 |
Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study.
Topics: Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tuberculosis | 2023 |
Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Humans; Iran; Laboratories; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Tuberculosis | 2022 |
Anti-Mycobacterial Activity of Flavonoid and Pyrimidine Compounds.
Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Drug Combinations; Flavonoids; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Pyrimidines; Rifampin; Tuberculosis | 2022 |
Mining of the Novel Virulent ATP-Binding Cassette Importers in
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; Clarithromycin; Clay; Genomics; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Phylogeny; Tuberculosis | 2022 |
Long-term outcome of nonsurgical treatment of nontuberculous mycobacterial cervicofacial lymphadenitis in children.
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Female; Humans; Infant; Lymphadenitis; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Treatment Outcome; Tuberculosis | 2021 |
Anti-tuberculosis Induced Stevens-Johnson Syndrome Due to Misdiagnosis of Mycobacterium Abscessus Urinary Tract Infection as Tuberculosis.
Topics: Anti-Bacterial Agents; Clarithromycin; Diagnostic Errors; Humans; Mycobacterium abscessus; Stevens-Johnson Syndrome; Tuberculosis; Urinary Tract Infections | 2021 |
Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana.
Topics: Adolescent; Adult; Aged; Clarithromycin; Drug Resistance, Bacterial; Female; Genotype; Ghana; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Prevalence; Retrospective Studies; Rifampin; Surveys and Questionnaires; Tuberculosis | 2017 |
In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics.
Topics: Acute Disease; Animals; Antitubercular Agents; Clarithromycin; Clindamycin; Disease Models, Animal; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; Half-Life; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2015 |
Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates.
Topics: Antitubercular Agents; Bacterial Proteins; Chaperonin 60; Chaperonins; Clarithromycin; DNA-Directed RNA Polymerases; DNA, Bacterial; DNA, Ribosomal; DNA, Ribosomal Spacer; Drug Resistance, Bacterial; Genes, rRNA; Humans; Korea; Molecular Sequence Data; Mycobacterium; Phylogeny; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid; Superoxide Dismutase; Tuberculosis | 2008 |
Successful clarithromycin desensitization in a multiple macrolide-allergic patient.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Desensitization, Immunologic; Dose-Response Relationship, Immunologic; Drug Hypersensitivity; Female; Humans; Mycobacterium avium; Treatment Outcome; Tuberculosis | 2010 |
Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Point Mutation; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 23S; Tuberculosis | 2011 |
Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum.
Topics: Amikacin; Anti-Infective Agents; Clarithromycin; Computer Simulation; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Models, Biological; Models, Theoretical; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Tuberculosis | 2012 |
Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications.
Topics: Administration, Oral; BCG Vaccine; Clarithromycin; Drug Administration Schedule; Female; Humans; Immunocompetence; Infant; Lymphatic Diseases; Mycobacterium bovis; Skin Diseases; Tuberculosis | 2002 |
Bronchus-associated lymphoid tissue lymphoma arising in a patient with bronchiectasis and chronic Mycobacterium avium infection.
Topics: Aged; Anti-Infective Agents; Bronchial Neoplasms; Bronchiectasis; Chronic Disease; Ciprofloxacin; Clarithromycin; Disease-Free Survival; Female; Humans; Lymphoma, B-Cell; Mycobacterium avium; Tuberculosis | 2004 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
Long-term cure of disseminated Mycobacterium avium infection in a cat.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clarithromycin; Clofazimine; Diagnosis, Differential; Doxycycline; Male; Mycobacterium avium; Tuberculosis | 2007 |
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Delivery Systems; Ethambutol; Female; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Specific Pathogen-Free Organisms; Tuberculosis | 2007 |
Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.
Topics: Animals; Clarithromycin; Dapsone; Drug Therapy, Combination; Female; Mice; Mice, Inbred C57BL; Mycobacterium avium; Tuberculosis | 1994 |
Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice.
Topics: Animals; Clarithromycin; Female; Humans; Macrophages; Mice; Mice, Inbred C57BL; Mycobacterium avium; Roxithromycin; Tuberculosis | 1995 |
Activities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse model.
Topics: Animals; Cells, Cultured; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Macrophages; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifabutin; Tuberculosis | 1995 |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice.
Topics: Animals; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1994 |
Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.
Topics: Animals; Antibiotics, Antitubercular; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifamycins; Tuberculosis | 1994 |
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Mycobacterium avium; Rifabutin; Rodent Diseases; Spleen; Time Factors; Tuberculosis | 1993 |
Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin.
Topics: Cells, Cultured; Clarithromycin; Humans; Intracellular Fluid; Kinetics; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium; Tuberculosis | 1993 |
[In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
Topics: Animals; Clarithromycin; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Tuberculosis | 1993 |
Antituberculosis activity of clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Female; Isoniazid; Macrophages; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1995 |
Clarithromycin is inactive against Mycobacterium tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Female; Mice; Mycobacterium tuberculosis; Spleen; Tuberculosis | 1995 |
In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antitubercular; Antitubercular Agents; Cell Death; Cells, Cultured; Clarithromycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Kanamycin Resistance; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 1996 |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Kanamycin; Lung; Male; Mice; Mycobacterium avium Complex; Rifampin; Rifamycins; Spleen; Tuberculosis | 1996 |
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Kanamycin; Lung; Male; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Rifamycins; Spleen; Tuberculosis | 1996 |
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Female; Mice; Mice, Nude; Mycobacterium avium; Predictive Value of Tests; Species Specificity; Tuberculosis | 1997 |
[In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antitubercular; Clarithromycin; Diclofenac; Drug Therapy, Combination; Female; Levofloxacin; Mice; Mice, Inbred BALB C; Mycobacterium avium; Ofloxacin; Rifamycins; Tuberculosis | 1997 |
Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cells, Cultured; Clarithromycin; Drug Synergism; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 1997 |
Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Clarithromycin; Clinical Trials as Topic; Cluster Analysis; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Follow-Up Studies; France; Humans; Multicenter Studies as Topic; Mycobacterium avium; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Recurrence; Serotyping; Treatment Failure; Tuberculosis | 1997 |
Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Female; Levofloxacin; Lung; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium avium; Ofloxacin; Phagocytosis; Rifamycins; Tuberculosis | 1998 |
Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Clarithromycin; Drug Therapy, Combination; Humans; Isoniazid; Lung; Mice; Mycobacterium avium; Spleen; Tuberculosis | 1998 |
IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice.
Topics: Adjuvants, Immunologic; Animals; Clarithromycin; Crosses, Genetic; Drug Therapy, Combination; Immunity, Innate; Injections, Intraperitoneal; Interferon-gamma; Interleukin-12; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, SCID; Mycobacterium avium; Rifabutin; Tuberculosis | 1998 |
Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Interleukin-12; Mice; Mice, Inbred BALB C; Mycobacterium avium; Spleen; Tuberculosis; Tumor Necrosis Factor-alpha | 1998 |
Long term treatment with clarithromycin for cryptosporidiosis and emergence of drug resistant disseminated infection due to Mycobacterium avium: case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Cryptosporidiosis; Drug Resistance, Microbial; Humans; Male; Mycobacterium avium; Tuberculosis | 1998 |
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Male; Mice; Mycobacterium avium; Tuberculosis | 1999 |
[Pseudotumoral abdominal granuloma concomitant with immune reconstitution after antiretroviral treatment].
Topics: Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; CD4 Lymphocyte Count; Clarithromycin; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Granuloma; HIV Infections; Humans; Lymphadenitis; Male; Mesentery; Mycobacterium avium; Peritoneal Diseases; Rifabutin; Time Factors; Tomography, X-Ray Computed; Tuberculosis | 2000 |
Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cell Wall; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2000 |
Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
Topics: Anti-Bacterial Agents; Cell Line; Clarithromycin; Epithelial Cells; Humans; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Ofloxacin; Pulmonary Alveoli; Rifamycins; Tuberculosis | 2000 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
Effects of recombinant granulocyte-colony stimulating factor administration during Mycobacterium avium infection in mice.
Topics: Animals; Antimicrobial Cationic Peptides; Antitubercular Agents; Blood Proteins; Clarithromycin; Ethambutol; Female; Granulocyte Colony-Stimulating Factor; Interferon-gamma; Interleukin-10; Mice; Mice, Inbred C57BL; Mycobacterium avium; Neutrophils; Recombinant Proteins; Rifabutin; Tuberculosis | 2001 |
Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Disease Models, Animal; DNA; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Interferon-beta; Interferon-gamma; Interleukin-12; Macrophages; Mice; Mice, Knockout; Monocytes; Mycobacterium avium; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligodeoxyribonucleotides; T-Lymphocytes; Thionucleotides; Tryptophan Oxygenase; Tuberculosis; Tumor Necrosis Factor-alpha | 2001 |
Chlamydia trachomatis and Mycobacterium tuberculosis lung infection in an HIV-positive homosexual man.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; HIV Seropositivity; Homosexuality, Male; Humans; Male; Mycobacterium tuberculosis; Sexual Behavior; Treatment Outcome; Tuberculosis | 2001 |
Activity of azithromycin against Mycobacterium avium infection in beige mice.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Culture Media; Drug Therapy, Combination; Erythromycin; Female; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium; Tuberculosis | 1992 |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis | 1992 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |